Intracellular protons control the affinity of skeletal muscle ATP-sensitive K+ channels for potassium-channel-openers  by Forestier, Cyrille et al.
Volume 325, number 3, 276-280 FEBS 12639 
0 1993 Federatton of European Biochemtcal Societtes 00145793/93/$6.00 
July 1993 
Intracellular protons control the affinity of skeletal muscle ATP-sensitive 
K’ channels for potassium-channel-openers 
Cyrille Forestier, Yves Depresle and Michel Vivaudou 
Laborutoire de Biophysique Molkulaire et Cellrrlaire (URA CNRS 520), Centre d’Etudes Nuclkaires de Grenoble, 85X. 
38041 Grenoble. Frunce 
Received 5 April 1993: revised version received 27 April 1993 
Levcromakalim. a potenttal antthypertensrve agent, is known to activate potassmm channels dependent on intracellular ATP (K-ATP channels). 
In inside-out patches excised from frog skeletal muscle. levcromakalim or a related compound, SR 47063, caused a strong and persistent activation 
of K-ATP channels at a cytoplasmtc pH of 7.1 However. at pH 6, these activators could no longer affect the K-ATP currents. Conversely. m the 
continuous presence of acttvator, lowermg pH from 7.1 to 6 returned channel activtty to its level m pH 6 alone. After wash-out of the activator. 
recovery from activation took minutes at pH 7.1 but only seconds at pH 6, thus ruling out an effect of protons on the activators m solution. These 
experiments suggest that K-channel-activators are unable to bmd to their receptor when it is protonated. and more generally, they provtde evidence 
at the microscoptc level for proton-induced allosteric modulatton of drug-receptor interaction 
Levcromakalim; SR 47063; K-ATP channel; pH: Rum rsculentu 
1. INTRODUCTION 
ATP-sensitive potassium channels are present in nu- 
merous types of cells [l] but the reason of their presence 
often remains enigmatic. K-ATP channels have none- 
theless generated unusual interest among pharmacolo- 
gists as they have been demonstrated to be the target of 
a number of molecules with potential therapeutic appli- 
cations. Among those molecules are the K-channel- 
openers (KCOs) exemplified by cromakalim and its ac- 
tive enantiomer levcromakalim [2]. We have tested 
levcromakalim on frog skeletal muscle K-ATP channels 
and found that its action was highly dependent on intra- 
cellular pH, since it became ineffective at acidic pH. The 
same observation was true of another more potent ben- 
zopyran derivative, SR 47063 [3]. Our data show that 
protons accelerate KCOs dissociation from their recep- 
tor. These observations, together with the fact that pro- 
tons, by themselves, can activate skeletal muscle K-ATP 
channels by shifting their ATP sensitivity [4], suggest 
that protonation of the K-ATP channel induces drastic 
changes in its conformation which transform the topol- 
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ogy of both the ATP and KCOs sites of fixation. In this 
respect, the parallelism between ATP and KCOs sup- 
ports the notion that they occupy a common site on the 
K-ATP channel complex. A preliminary report of some 
of the results presented here has been published in ab- 
stract form [5]. 
2. MATERIALS AND METHODS 
Using the patch-clamp technique [6] m the excised inside-out mode, 
currents through K-ATP channels were recorded from sarcolemmal 
blebs elicited by mechanical cleavage of fibers dissected from the 
thofibularis thigh muscle of the adult frog. Runu rsculentu [7]. 
The patch pipette contained 150 mM K’. 136 mM Cl-, 2 mM Mg”, 
and 10 mM PIPES. The cytoplasmic face of the patch was bathed m 
solutions which all contained 150 mM K’, 40 mM CIT. 1 mM EGTA. 
IO mM PIPES, and methanesulfonate- as the remaining anions. Mg” 
(5 mM) was present only in the solution containing 3 mM ATP. The 
pH values were obtained with addttton of KOH or KCI and were 
found to remain stable during the course of an experiment. 
Unless otherwise specified, pH was set to 7.1 and the membrane 
potential V, was -50 mV. Experiments were conducted at room 
temperature (23%24”C). ATP (potassium salt) was purchased from 
Sigma. Levcromakalim, also known as BRL 38227 or lemakalim 
(Smith Kline Beecham Pharmaceuttcals, UK) and SR 47063 (Sanofi 
Recherche, France) were added from stock soluttons (respectively, 100 
mM and 10 mM) in DMSO. DMSO alone was without effects on 
K-ATP channel activity at all pHs used. 
The intracellular face of the patches was perfused by placing the tip 
of the patch pipette m the outlet flow of one of 36 polyethylene tubes 
from whtch the different solutions continuously flowed by gravity, 
Tubes were mounted on a revolving barrel linked to a stepping motor 
interfaced to a PC-compatible computer. This device (rapid-solutton- 
changer RSC-100 commercialized under licence by Bto-Logic. France) 
was designed to permit rapid swttchmg from one solution to any of 
the others and automation of perfuston protocols. Signals were ac- 
quired and processed as previously described [S] 
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3. RESULTS 
Intracellular acidosis is known to activate K-ATP 
channels in skeletal muscle by reducing their sensitivity 
to inhibition by ATP [4]. The same mechanism underlies 
the effects of KCOs in cardiac muscle [9]. 
Accordingly, in the presence of partially inhibiting 
doses of ATP (100-300 PM) on the cytoplasmic side of 
the patch, lowering pH from 7.1 to 6 or applying levcro- 
makalim (100 ,DM) both caused clear increases in the 
activity of skeletal muscle blebs K-ATP channels. Acti- 
vation by low pH was reversible within seconds while 
activation by levcromakalim persisted for minutes after 
removal of the activator. When pH was lowered in the 
presence of levcromakalim, channel activity could ei- 
ther decrease as in Fig. 1A and C (22 out of 44 patches), 
increase as in Fig. 2 (6 out of 44 patches), or remain 
constant (16 out of 44 patches). After the initial puzzle- 
ment over this apparent lack of coherence, we noticed 
that in fact in all patches tested the level of K-ATP 
current in pH 6 was roughly the same with or without 
levcromakalim, suggesting that acidosis neutralized the 
action of levcromakalim. In the patch of Fig. 1, pH 
6-induced activity was less than levcromakalim-induced 
activity and consequently in the presence of levcro- 
A - I 
100 PM ATP 
makalim pH 6 reduced channel activity toward its value 
in pH 6 alone (Fig. 1A and C). In the patch of Fig. 2, 
pH 6-induced activity was greater than levcromakalim- 
induced activity and in the presence of levcromakalim 
pH 6 increased channel activity toward its value in pH 
6 alone (Fig. 2). 
The lack of efficacy of levcromakalim at acidic pH 
was further demonstrated in 38 patches where levcro- 
makalim was found to cause a strong activation of K- 
ATP channels (i.e. at least 4-fold increase in channel 
activity) at pH 7.1 but remained ineffective (i.e. less than 
10% change in activity) when applied after pH had been 
reduced to 6 (Fig.lB). 
In order to test the specificity of these pH effects, 
experiments were repeated with another KCO, SR 
47063 (50-100 PM), which belongs to the benzopyran 
family of KCOs like levcromakalim but has been shown 
to be more potent in relaxing smooth muscle in vivo [3]. 
As illustrated in Fig. 3, additions of SR 47063 had no 
effect at pH 6 but resulted in dramatic activation of 
K-ATP channels at pH 7.1; conversely, in the continu- 
ous presence of the activator lowering pH from 7.1 to 
6 returned channel activity to the activator-free pH 6 
levels. Similar recordings were acquired in 13 patches. 
These results could be explained simply if proton in- 
3mMATP , 
Levcromakalim 
B 
3 mM ATP 
I 100 PM ATP 
3 mM ATP 
I 
PH6 
Levcromakalim 
100 LIM ATP 
Levcromakalim 
Fig. 1. Lowering intracellular pH from 7.1 to 6 reverses (A and C) and prevents activation of K-ATP channels by 100 ,uM levcromakalim. Traces 
were recorded from the same patch in the order presented with a gap of 20 s between A and B and 10 s between B and C. In this and other figures. 
bath pH was 7.1 except where indicated by the pH 6 bars. Patch 2C1705. 
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3 mM ATP 
pL 300 PM ATP 
3mMATP 
300 PM ATP 
3 mM ATP 
I 
PH6 
Levcromakalim 
Fig. 2. Acidification from pH 7.1 to 6 elicits the same level of channel activity with and without 100,uM levcromakahm in a case where acidification 
caused a greater increase in K-ATP current than levcromakalim. Patch 293008. 
teraction with KCOs modified their affinity or efficacy. 
In order to exclude this hypothesis, pH sensitivity of 
levcromakalim was directly assessed by titration. The 
titration curve of levcromakalim (1 mM in H,O) re- 
vealed no effective buffering capacity in the range pH 
4-10 and therefore no particular acidic or basic charac- 
ter. The opposite would have been surprising as the 
chemical structure of either levcromakalim or SR 47063 
does not point to any obvious site of protonation. 
The possibility of a more subtle interaction between 
KCOs and pH was further ruled out by taking advan- 
tage of the poor reversibility of the channel activation 
by KCOs. After a brief application of either levcro- 
makalim or SR 47063 (100 PM), significant K-ATP 
current activation can persist for minutes at a neutral 
pH of 7.1 after wash-out of the activator (Fig. 4), prob- 
ably reflecting the slow dissociation rate of the drug 
from the channel. When pH is lowered to 6 for a short 
period while the drug is no longer in solution but still 
bound to the channel, the current rapidly and perma- 
nently returns to its control level (Fig. 4) suggesting that 
the interaction of protons with the K-ATP channel trig- 
gers a loss of affinity for the activator. The experimental 
protocol used in Fig. 4 yielded equivalent results in 15 
patches (10 patches with levcromakalim and 5 patches 
with SR 47063) where return to control level took more 
than 50 s at pH 7.1 but less than 3 s at pH 6. This type 
of protocol where KCOs and pH 6 are applied in 0 ATP 
also demonstrates that: (1) although activation by 
KCOs is seen only in the presence of ATP, KCOs are 
able to bind to the channel even in the absence of nucle- 
otides: and (2) the effects of acidic pH on KCOs binding 
A , . 
100 pM ATP 
SR47063 SR47063 
B 
100 uMATP 
SR47063 SR47063 
PH6 pH6 PH6 PH6 
IOpAl 
20s 
Fig. 3. Lowering pH from 7.1 to 6 blocks activation by 100pM SR 47063. Trace B was recorded 20 min later than A from the same patch. Patch 
320203. 
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SR47063 PH6 
3 mM ATP 
, OATP , 3 ATP -m 3ATp IOATP, 3ATP 
B 
Levcromakalim PH6 
3 mMATP 
0 ATP 
3ATP 
I ,, OATP 
3 ATP 
r-L OATP 
3ATP , 
Fig. 4. A brief acidification from pH 7.1 to 6 accelerates the wash-out of the persistent activation which remains after a short application of SR 
47063 or levcromakalim (100 ,uM). (A) V,,, = -50 mV. Patch 320102. (B) v,,, = -80 mV. Patch 38M3. 
do not require ATP as would be the case if variations 
in the proportion of the ionized forms of ATP (HATP3- 
and ATp4) played a role. 
Application of acidic solutions was used in many 
other patches as a practical means of speeding up recov- 
ery from KCOs activation (see for example third appli- 
cation of pH 6 in Fig. 3). 
4. DISCUSSION 
We have investigated in this work the pH-dependence 
of the action of two K-channel-openers of the benzo- 
pyran family, levcromakalim and SR 47063, on am- 
phibian skeletal muscle K-ATP channels. At a normal 
cytoplasmic pH of 7.1. KCOs opened K-ATP channels 
in the presence of inhibiting doses of ATP. Acidification 
to pH 6 prevented this activation and could reverse it 
rapidly, suggesting that protons reduce the affinity of 
the drugs for their binding site. In our experimental 
system, one can identify 3 possible protonation targets 
which could mediate these effects: the KC0 molecule, 
the ATP molecule, or the K-ATP channel complex. 
The evidence that protons act directly on the channel 
rather than on soluble constituents comes from the ex- 
periments of Fig. 4, where acidic pH was applied in the 
absence of either KCOs or ATP and found to accelerate 
the dissociation of the KCOs from the K-ATP channel. 
In addition, these experiments indicate that, if activa- 
tion by KCOs requires ATP, binding of KCOs does not. 
More importantly, they demonstrate that the block by 
protons of KC0 activation involves a change in channel 
affinity for the KCOs rather than a change in the effi- 
cacy of the bound KCOs. 
The channel protonation site mediating this effect is 
likely to be distinct from the KC0 binding site, but 
allosterically linked to it. Indeed if KCOs and protons 
shared the same site, one would not expect KC0 disso- 
ciation to be dependent on proton concentration. By the 
same argument, one would expect the two sites to be 
localized within the same complex if not the same pro- 
tein. 
In skeletal muscle [4]. protons are known to interfere 
strongly with ATP binding, and they cause channel ac- 
tivation, as we have verified in this work, by relief of 
inhibition. Thus protons, over the same range of con- 
centrations, reduce channel affinity for ATP just as they 
reduce affinity for KCOs. This similarity reinforces the 
notion of a common site for ATP and KCOs already 
suggested by the apparent competition between KCOs 
and ATP reported in cardiac muscle [9,10]. Therefore 
our data would be consistent with a model where KCOs 
and ATP share a single binding site allosterically cou- 
pled with the proton-binding site or sites. 
In other tissues, particularly cardiac muscle [l l] and 
B-cells [12], pH has either very weak or opposite effects 
on the ATP dependence of K-ATP channels. These 
channels may lack the protonation site of skeletal mus- 
cle K-ATP channels. In these tissues it would be desira- 
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ble to test the pH dependence of KC0 activation to 
obtain further insights in the validity of the proposed 
model and in the tissue specificity of this model. The 
experiments that we have performed with benzopyran 
K-channel-activators could also serve as an assay for 
other structurally-distinct KCOs [2] to investigate 
whether KCOs bind to a common target site, as hinted 
by binding studies [13], and whether they exploit the 
same mechanism of action. 
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